Laurie E. Littlepage
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms 5
- Oncology top 2%
- Cancer Cells and Metastasis 9
- Peptidase Inhibition and Analysis 4
- Cancer-related Molecular Pathways 3
- Cell Biology top 1%
- Microtubule and mitosis dynamics 6
- Molecular Biology top 2%
- Genomics and Chromatin Dynamics 5
- RNA modifications and cancer 4
- Immunology and Allergy top 2%
-
- Spectroscopy Techniques in Biomedical and Chemical Research 3
- Co-authors
- Joan RudermanZena WerbMelissa L. FishelJun WuKaren RichardsReginald HillAnn E. ZeleniakMikala Egeblad
- Cited by
- Cancer ResearchOncologyCell Biology
- Journals
- Nature (2 papers)Proceedings of the National Academy of Sciences (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- United StatesMexicoKenya
In The Last Decade
Laurie E. Littlepage
41 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 1.2k
- Oncology 1.5k
- Cell Biology 860
- Molecular Biology 2.7k
- Immunology and Allergy 214
Countries citing papers authored by Laurie E. Littlepage
This map shows the geographic impact of Laurie E. Littlepage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie E. Littlepage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie E. Littlepage more than expected).
Fields of papers citing papers by Laurie E. Littlepage
This network shows the impact of papers produced by Laurie E. Littlepage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie E. Littlepage. The network helps show where Laurie E. Littlepage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laurie E. Littlepage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 29 | |
| 8 | 2020 | 62 | |
| 9 | 2019 | 60 | |
| 10 | 2018 | 2 | |
| 11 | 2018 | 56 | |
| 12 | 2018 | 36 | |
| 13 | Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cellsbreakdown → | 2016 | 616 |
| 14 | 2013 | 103 | |
| 15 | 2012 | 54 | |
| 16 | 2010 | 169 | |
| 17 | 2008 | 56 | |
| 18 | 2008 | 287 | |
| 19 | Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instabilitybreakdown → | 2005 | 1021 |
| 20 | 2002 | 242 |
About Laurie E. Littlepage
Laurie E. Littlepage is a scholar working on Cancer Research, Oncology and Biophysics, having authored 41 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Microtubule and mitosis dynamics (6 papers), Protease and Inhibitor Mechanisms (5 papers), Genomics and Chromatin Dynamics (5 papers), Peptidase Inhibition and Analysis (4 papers), RNA modifications and cancer (4 papers), Spectroscopy Techniques in Biomedical and Chemical Research (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.5k citations) and Cell Biology (860 citations). Laurie E. Littlepage has collaborated with scholars based in United States, Mexico and Kenya. Frequent co-authors include Joan Ruderman, Zena Werb, Melissa L. Fishel, Jun Wu, Karen Richards, Reginald Hill, Ann E. Zeleniak, Mikala Egeblad, Derek C. Radisky and Hong Liu. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.